Market Tracker

04/26 1:11pm ET

Shire PLC (NASDAQ:SHPG)

159.78
Delayed Data
As of 12:56pm ET
 +1.41 / +0.89%
Today’s Change
123.73
Today|||52-Week Range
192.15
+3.00%
Year-to-Date
Strong Revenue and Earnings: CVS Health, Rush
11:50am / GuruFocus News - Paid Partner Content
Shire (SHPG) Turns Down Takeda's Third Buyout Proposition
Apr 20 / Zacks.com - Paid Partner Content
Why Did Allergan Abandon the Shire Hunt?
Apr 25 / GuruFocus News - Paid Partner Content
Biotech M&A Ratchets Up to a New Level
Apr 20 / GuruFocus News - Paid Partner Content
Facebook faces Wall Street; Shire deal; Credit Suisse soars
Apr 25 / CNNMoney.com
GE earnings; Wells Fargo fine; Pound pummeled
Apr 20 / CNNMoney.com
Takeda freaks out investors with $64 billion bid for Shire
Apr 24 / CNNMoney.com
Takeda sweetens $60 billion Shire pitch as rival bows out
Apr 20 / CNNMoney.com
Shire's Tug of War
Apr 23 / GuruFocus News - Paid Partner Content
Why Is Allergan (AGN) Stock Falling Today?
Apr 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close158.37
Today’s open162.87
Day’s range159.51 - 162.92
Volume1,266,396
Average volume (3 months)1,494,823
Market cap$40.5B
Data as of 12:56pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+1,014.78%
Earnings growth (this year)+3.59%
Earnings growth (next 5 years)+5.41%
Revenue growth (last year)+35.39%
P/E ratio11.4
Price/Sales3.08
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+4.15+2.67%
REGNRegeneron Pharmaceut...+7.40+2.34%
BAXBaxter International...+3.11+4.68%
ALXNAlexion Pharmaceutic...+12.67+11.95%
Data as of 1:11pm ET, 04/26/2018

Financials

Last reporting dateApril 26, 2018
EPS forecast (this quarter)$3.71
Annual revenue (last year)$15.3B
Annual profit (last year)$4.3B
Net profit margin28.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Director
Thomas J. W. Dittrich
Corporate headquarters
Dublin, Dublin

Forecasts